Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

NCT06066112 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalence
Schizophrenia

Interventions

DRUG: Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.

Sponsor

The Affiliated Hospital of Qingdao University